Progressive Hypoxia-on-a-chip: An In Vitro Oxygen Gradient Model for Capturing the Effects of Hypoxia on Primary Hepatocytes in Health and Disease by Kang, Young Bok Abraham et al.
Digital Commons @ George Fox University 
Faculty Publications - Biomedical, Mechanical, 
and Civil Engineering 
Department of Biomedical, Mechanical, and 
Civil Engineering 
2019 
Progressive Hypoxia-on-a-chip: An In Vitro Oxygen Gradient Model 
for Capturing the Effects of Hypoxia on Primary Hepatocytes in 
Health and Disease 
Young Bok Abraham Kang 
Jinsu Eo 
Beyza Bulutoglu 
Martin L. Yarmush 
O. Berk Usta 
Follow this and additional works at: https://digitalcommons.georgefox.edu/mece_fac 
 Part of the Biomedical Engineering and Bioengineering Commons 
Progressive hypoxia‐on‐a‐chip: An in vitro oxygen gradient
model for capturing the effects of hypoxia on primary
hepatocytes in health and disease
Young Bok (Abraham) Kang1,2 | Jinsu Eo1 | Beyza Bulutoglu1 | Martin L. Yarmush1,3 |
O. Berk Usta1
1Department of Surgery, Center for
Engineering in Medicine, Harvard Medical
School, Massachusetts General Hospital,
Shriners Hospitals for Children‐Boston,
Boston, Massachusetts
2Department of Mechanical & Civil &
Biomedical Engineering, College of
Engineering, George Fox University,
Newberg, Oregon
3Department of Biomedical Engineering,
Rutgers University, Piscataway, New Jersey
Correspondence
O. Berk Usta, Department of Surgery, Center
for Engineering in Medicine, Harvard Medical
School, Massachusetts General Hospital,
Shriners Hospitals for Children‐Boston,
51 Blossom Street, Boston, MA 02114.
Email: berkusta@gmail.com
and ousta@mgh.harvard.edu
Funding information
National Institutes of Health, Grant/Award
Numbers: 1F32EB026916, 1R21EB020192,
5P41EB002503, 5R01EB023812; Shriners
Hospital for Children, Grant/Award Number:
84311
Abstract
Oxygen is vital to the function of all tissues including the liver and lack of oxygen, that
is, hypoxia can result in both acute and chronic injuries to the liver in vivo and ex vivo.
Furthermore, a permanent oxygen gradient is naturally present along the liver
sinusoid, which plays a role in the metabolic zonation and the pathophysiology of liver
diseases. Accordingly, here, we introduce an in vitro microfluidic platform capable of
actively creating a series of oxygen concentrations on a single continuous microtissue,
ranging from normoxia to severe hypoxia. This range approximately captures both
the physiologically relevant oxygen gradient generated from the portal vein to the
central vein in the liver, and the severe hypoxia occurring in ischemia and liver
diseases. Primary rat hepatocytes cultured in this microfluidic platform were exposed
to an oxygen gradient of 0.3–6.9%. The establishment of an ascending hypoxia
gradient in hepatocytes was confirmed in response to the decreasing oxygen supply.
The hepatocyte viability in this platform decreased to approximately 80% along the
hypoxia gradient. Simultaneously, a progressive increase in accumulation of reactive
oxygen species and expression of hypoxia‐inducible factor 1α was observed with
increasing hypoxia. These results demonstrate the induction of distinct metabolic and
genetic responses in hepatocytes upon exposure to an oxygen (/hypoxia) gradient.
This progressive hypoxia‐on‐a‐chip platform can be used to study the role of oxygen
and hypoxia‐associated molecules in modeling healthy and injured liver tissues. Its
use can be further expanded to the study of other hypoxic tissues such as tumors as
well as the investigation of drug toxicity and efficacy under oxygen‐limited conditions.
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1 | INTRODUCTION
Oxygen and its availability are vital to the function of tissues and
cellular processes in both health and disease. Variations in oxygen
levels through regular physiological processes and/or changes of
oxygen supply into blood and tissues due to disease, sudden trauma,
or other injuries, are important determinants of cell metabolism and
survival. The availability of oxygen can also be highly modulated for
thick cancerous tissues, that is, tumors, and for external/internal
wounds both of which result in poor oxygenation of a significant
amount of cells in the specific tissue. Such deprivation of oxygen
supply is called “hypoxia”. In the case of wounds, it has been well
documented that such hypoxia leads to significantly slower healing
responses(Castilla, Liu, & Velazquez, 2012). In contrast, the highly
hypoxic environment—especially at the core—of a tumor leads
cellular adaptations for cancer cells which promote their survival
through activation of glycolysis pathway genes among others
(Covello et al., 2006; Keith, Johnson, & Simon, 2011; Moreno‐
Manzano et al., 2010).
The liver, with its significantly high oxygen consumption under
normal conditions, is particularly of interest in terms of its responses
to natural and gradual gradients of oxygen concentration in the liver
sinusoid, and also to hypoxia during a traumatic event or disease. In a
healthy liver tissue—along with other genetic, hormonal, and
nutritional drivers—a gradient of oxygen due to its consumption
along the sinusoid is an important driver of metabolic heterogeneity
of the liver tissue which is specifically termed as “liver zonation”. In
healthy liver tissue, the periportal blood with an oxygen partial
pressure of 60–65mmHg (7.9–8.6% O2) flows into the liver sinusoid
and drains out to the central vein at an oxygen partial pressure of
30–35mmHg (3.9–4.6% O2; Brooks, Eastwood, Beckingham, &
Girling, 2004; Brooks, Hammond, Girling, & Beckingham, 2007;
Kietzmann, 2017; M, 1996; Wolfle, Schmidt, & Jungermann, 1983).
Perhaps more importantly, this physiological oxygen gradient is
also a driver of both heterogeneity and progressive development of
disease(Bulutoglu et al., 2019; Hall et al., 2017), as demonstrated in
our recent work that recapitulated the oxygen mediated zonation of
lipid accumulation(Bulutoglu et al., 2019). A diseased and/or
traumatically injured liver tissue further exhibits abnormal symptoms
such as loss of normal hepatic metabolic functions, disrupted
homeostasis, and inflammation(Albillos, Lario, & Alvarez‐Mon,
2014; Nath & Szabo, 2012; Robinson, Harmon, & O’Farrelly, 2016).
These symptoms are often closely associated with insufficient oxygen
supply and severe hypoxia corresponding to <2% O2. Prolonged
oxygen tension below this 2% threshold level disrupts the oxygen
balance and is characterized as tissue ischemia. This results in
abnormal hepatic metabolic function due to the activation and
release of key mediators such as reactive oxygen species (ROS) and
hypoxia‐inducible factors (HIFs). ROS are commonly upregulated
during pathogenesis and pathological state; and subsequently
accelerate liver injury and disease including liver fibrosis, steatosis,
and liver cancer (Figure 1; Carreau, El Hafny‐Rahbi, Matejuk, Grillon,
& Kieda, 2011; Nath & Szabo, 2012; Paik, Jung, Lee, Park, & Lee,
2017; Semenza, 2012). In general, such disruption of oxygen supply
plays a crucial role in the process of liver pathophysiology and
pathogenesis (Ebert, 2006; Jaeschke, 2000; Lefere et al., 2016; Nath
& Szabo, 2012).
Despite this vital importance of oxygen availability, the cellular
mechanisms and regulatory machinery associated with hypoxia, ROS,
and HIFs in the healthy and diseased liver tissues are not well
investigated. While few studies attempt to study the effect of oxygen
concentration on liver physiology, they are limited by their
physiologically irrelevant oxygen concentrations. Most of these
platforms involve 2D well plate cultures, which can simulate one
zone of the liver at a time, use a reference point of 20% O2 (the
atmospheric oxygen pressure), and focus on 1% or 2% O2 to mimic
hypoxia (Carreau et al., 2011; Copple, 2010; Popovici et al., 2001;
Qin et al., 2015). These conditions do not reflect the in vivo liver
microenvironment with continuous tissue under an oxygen gradient
presence (Figure 1). Some of the more advanced platforms,
simulating a physiologically relevant zonation, still have limitations
as they employ passive oxygen gradient generation, where the
gradients are generated by cellular consumption (Allen, Khetani, &
Bhatia, 2005; Camp & Capitano, 2007; Cho et al., 2007; Park,
Berthiaume, Toner, Yarmush, & Tilles, 2005). Similarly, spheroid
models can naturally give rise to the spontaneous creation of oxygen
gradients (Anada, Fukuda, Sai, & Suzuki, 2012; Ko et al., 2019; Yu
et al., 2017); however, the reproducibility of such gradients relies
heavily on both the tight distribution of spheroid sizes and the highly
reproducible oxygen consumption rates of cells.
A recent study demonstrated an actively‐controlled oxygen
gradient model, generated in an open‐well cell culture, where oxygen
diffusion occurred through gas‐permeable polydimethylsiloxane
(PDMS; Lo, Sinkala, & Eddington, 2010). One limitation of this
microfluidic platform is the discrepancy of oxygen levels along with
the media at the top and the bottom of the cell culture. Another study
recapitulated an oxygen gradient of 4–9% achieved by oxygen
diffusion from air‐gas (20% O2 and 5% CO2). A statistically significant
change in expression levels of PEPCK and GK enzymes, upregulated in
periportal and pericentral regions, respectively, was demonstrated in
two zones of the device (Sato, Kadokura, Uchida, & Tsukada, 2014).
Several other microfluidic devices have been presented to create
controllable hypoxia (oxygen) gradients using mixtures of oxygen‐
nitrogen gases (Allen et al., 2005; Camp & Capitano, 2007; Chang
et al., 2014; De Miguel et al., 2016; Lo et al., 2010; Polinkovsky,
Gutierrez, Levchenko, & Groisman, 2009). Based on our experience,
the use of gas diffusion via a membrane may alter CO2 concentration
and cause air bubble generation within the device. Moreover, these
devices showed some limitations in providing distinct sample collec-
tion to analyze the functional and metabolic activities of cells
differentially expressed along an oxygen gradient.
A multizone oxygen gradient model, allowing for sample collec-
tion from different gradient sections, would be a step forward, that
can simultaneously capture both normoxic and hypoxic conditions in
a single microfluidic device on a single connected tissue. This
approach can facilitate more gradual and comprehensive demonstra-
tion of zone‐specific metabolic activity and gene expression profile of
hepatocytes exposed to oxygen gradients. In addition, such technol-
ogy would allow for the investigation of the effects of hypoxia on
hepatocytes under healthy conditions and in the pathophysiological
state of liver tissue. In our previous studies, we developed a
microfluidic platform, the “Metabolic Patterning on a Chip (MPOC)
device”, and successfully demonstrated in vitro zonation of primary
rat and human hepatocytes via this platform. The MPOC device was
able to create actively‐controlled gradients of inducers or hormones,
and thus enforce the creation of metabolic patterns across
microscopic tissues (Kang, Eo, Mert, Yarmush, & Usta, 2018;
McCarty, Usta, & Yarmush, 2016).
Here, we used the MPOC device to introduce an in vitro oxygen/
hypoxia gradient for a short‐time period in the range of 0.3–6.9% O2
using a chemical oxygen‐quenching approach (Jiang et al., 2011). At
the maximum level, this oxygen concentration range represents an
average oxygen tension value for healthy liver tissue and at the
lowest end, it represents a severely hypoxic condition. Through this
approach, we were able to understand and contrast hepatic
phenotypes under normal oxygenation levels and severe hypoxia,
which represents conditions such as acute injuries, temporary
disruptions to the blood supply, and ischemia. Specifically, we
assessed the short‐term responses to an oxygen gradient in a liver
microtissue of primary rat hepatocytes in terms of hypoxia‐
associated factors (e.g., ROS and HIFs) and confirmed the formation
of a patterned molecular injury response across the MPOC device.
Since here we only focused on short‐term and primarily traumatic/
ischemic injury phenotypes, we did not assess the zonated
phenotypes and metabolism of hepatocytes which usually take about
24–48 hr to establish (Berndt & Holzhutter, 2018; Cassim, Raymond,
Lapierre, & Bilodeau, 2017). However, long‐term studies are indeed
possible with oxygen concentrations in full physiological range in the
MPOC device toward recapitulation of the effects of oxygen tension
on the progression of certain diseases such as nonalcoholic fatty liver
disease (NAFLD) (Bulutoglu et al., 2019).
2 | MATERIALS AND METHODS
2.1 | Microfluidic device design and fabrication
The design and fabrication of the gradient‐generating MPOC device
were explained in detail in our previous study (Kang et al., 2018).
Briefly, it is composed of a gradient generator (width [w] × height [h]:
75 × 200 µm) and a cell culture chamber (wiggle shape, w × h × length
[l]: 10,000 × 200 × 1,700 µm), in addition to inlets and outlets for
media flow and cell seeding. All devices used in this study were
fabricated by PDMS replica molding from a SU‐8 template made with
the help of photolithography technology, as previously described
(Kang et al., 2018; McCarty et al., 2016). The PDMS microfluidic
device was bonded on a glass microscope slide (w × l: 25 × 75mm;
Thermo Fisher Scientific, Grand Island, NY) after oxygen plasma
treatment.
F IGURE 1 Oxygen levels in the liver under normoxic and hypoxic conditions. The oxygen ranges of the normoxia‐hypoxia for both the
human liver and the rat liver are similar. Under normoxia, the liver operates in an oxygen range of 3.9–8.6%. In liver ischemia and injured liver
tissue, hypoxia corresponding to <2% O2 is observed. Hypoxia causes reactive oxygen species (ROS) accumulation in cells, which leads to
cellular damage and eventually to apoptosis. Hypoxia‐associated factors (e.g., HIFs) are expressed under hypoxic conditions to protect cells from
oxidative stress and to adjust to the oxygen‐deprived environment. Non‐parenchymal cells (e.g., hepatic stellate cells and Kupffer cells) are also
activated under hypoxia. Cell culture systems using a standard well plate and a hypoxic chamber are not physiologically relevant systems as
they capture a single zone of oxygen and nutrients. These cannot fully capture the different behaviors of HIFs that are activated at different
oxygen levels in vivo [Color figure can be viewed at wileyonlinelibrary.com]
2.1.1 | Isolation of primary rat hepatocytes and cell
culture
Primary rat hepatocytes were freshly isolated from adult female
Lewis rats (Charles River Laboratories, MA) according to the protocol
#2011N000111 approved by the Institutional Animal Care and Use
Committee (Dunn, Tompkins, & Yarmush, 1991; Seglen, 1976).
Approximately 3.1–4.1 × 104 hepatocytes with 90–95% viability
were cultured in the cell culture chamber of the device that was
coated with 50 μg/ml fibronectin (Sigma‐Aldrich, St. Louis, MO) for
20–40min at 37°C and 10% CO2 as described previously (Kang et al.,
2018; McCarty et al., 2016). The cells were seeded and cultured at
37°C and 10% CO2 in Dulbecco’s modified eagle’s medium (DMEM;
Life Technologies, Carlsbad, CA) supplemented with 10% fetal bovine
serum (Sigma‐Aldrich), 0.5 U/ml insulin, 7 ng/ml glucagon, 20 ng/ml
epidermal growth factor, 7.5 μg/ml hydrocortisone, 200 U/ml peni-
cillin, 200 μg/ml streptomycin, and 50 μg/ml gentamycin.
2.2 | Generation of the oxygen gradient in the
MPOC device
To create the oxygen gradient, sulfite and cobalt were used for
removing oxygen and for accelerating oxygen depletion, respectively
(Abudara, Jiang, & Eyzaguirre, 2002; Grasselli, Basini, Bussolati, &
Bianco, 2005; Jiang et al., 2011; Shimizu et al., 1996). Oxygen‐free
media was prepared by dissolving 0.1 g sodium sulfite (Na2SO3) and
50 µl cobalt nitrate (Co(NO3)2) in 10ml DMEM media to result in a
final concentration of 1% sulfite and 100 µM cobalt in the media
(GmbH, 2013). Oxygen‐dissolved media was the DMEM media.
DMEM media (one inlet) and DMEM supplemented with 1% sulfite
and 100 µM cobalt (the other inlet) flew into the gradient generator
of the device. The oxygen gradient generation was tested in the cell
culture chamber of the device by mixing DMEM media (0% sulfite/
0 µM cobalt) and DMEM supplemented with 1% sulfite and 100 µM
cobalt at 30–120 µl/hr.
2.3 | Measurement of dissolved oxygen (DO) in
aqueous solution
Solutions of different sulfite and cobalt concentrations, 0% sulfite/
0 µM cobalt, 0.25% sulfite/25 µM cobalt, 0.5% sulfite/50 µM cobalt,
0.75% sulfite/75 µM cobalt, 1% sulfite/100 µM cobalt, 100 µM cobalt,
1% sulfite, and 95% N2/5% CO2 in water, were prepared in 50ml
conical tubes. The DO level of each aqueous solution was measured
by the DO meter (EW35643‐14; Oakton DO6, Vernon Hills, IL) with
an accuracy of ±1.5% of the full‐scale range.
For detection of the oxygen levels in the MPOC device, the
VisiSens system with a VisiSens 2D sensor film (PreSens/TD system
GmbH, Germany) was used according to the manufacturer’s
instructions. The VisiSens sensor film was adhered to the glass
microscope slide using super glue. The microfluidic device was
attached to the VisiSens sensor film after oxygen plasma treatment.
The oxygen level in the microfluidic device was detected by the
VisiSens system with a modular detector unit for 2D read‐out of
fluorescent oxygen sensor foils. Oxygen‐sensing images were
visualized by VisiSens AnalytiCal 1 software, followed by the
quantification of the oxygen profile through the ImageJ software
(NIH, Bethesda, MD).
2.4 | Perfusion of cells with the oxygen gradient
The device seeded with primary hepatocytes was connected to the
perfusion system through Tygon tubing as described previously
(Kang et al., 2018; McCarty et al., 2016). 20–24 hr after cell seeding,
cells were perfused with the oxygen gradient generated by mixing
DMEM media and DMEM supplemented with 1% sulfite and 100 µM
cobalt at 120 µl/hr for 2 hr.
2.4.1 | Immunofluorescence assay
Following the oxygen gradient exposure, the microfluidic device was
detached from the perfusion system. Cells were fixed with 4%
paraformaldehyde for 15min at room temperature. We then cut
around the pattern of the culture chamber of the PDMS layer on the
surface of the glass microscope slide with a razor blade. The PDMS
layer was peeled off from the glass microscope slide while cells were
still attached to the glass slide. Next, the cells were incubated with
0.25% Triton X‐100 in phosphate‐buffered saline (PBS) for 10min,
followed by incubation with 1% bovine serum albumin (BSA) and
22.52mg/ml glycine in PBST (PBS + 0.1% Tween 20) for 30min to
block unspecific binding of antibodies. Cells were then incubated
overnight at 4°C with the diluted primary antibody solution in 1%
BSA in PBST. HIF1α antibody (anti‐HIF1α, mouse monoclonal
antibody, 1:50, NB100–105; Novus Biologicals, Littleton, CO) and
hypoxyprobe ATTO 594 (1:100, mouse monoclonal antibody con-
jugated to ATTO 594 fluorophore; Hypoxyprobe, Burlington, MA)
were used to detect pimonidazole adducts in hypoxic cells. The next
day, cells were incubated with goat antimouse conjugated secondary
antibody (Texas Red, 1:1,000, ab6787; Abcam, Cambridge, MA) in 1%
BSA for 1 hr at room temperature in the dark. Cell nuclei were
counterstained with Hoechst (1:2,000, 33258; Thermo Fisher
Scientific). Images were obtained by the EVOS fluorescence micro-
scope (EVOS FL; Thermo Fisher Scientific).
2.5 | Cell viability assay and detection of ROS
For cell viability analysis, cells in the device were stained with the
live/dead cell assay kit (L3224; Thermo Fisher Scientific) or
tetramethylrhodamine methyl ester (TMRM; 500 nM; Thermo Fisher
Scientific) for 15–20min at 37°C according to the manufacturer’s
instructions. For the detection of ROS, cells were stained with ROS
detection reagent—CM‐H2DCFDA (C6827; Thermo Fisher Scientific)
according to the manufacturer's protocol. Cell nuclei were stained
with Hoechst (33258; Thermo Fisher Scientific). Images were
obtained using the EVOS fluorescence microscope. The average
fluorescence intensity across the width of the device was quantified
using the ImageJ software. For the well plate experiments,
PrestoBlue reagent (Thermo Fisher Scientific) was used according
to the manufacturer’s protocol.
2.5.1 | RNA isolation and RT‐PCR analysis
Hepatocytes were harvested from each channel of the cell culture
chamber after induction with the hypoxia gradient. Total RNA was
isolated using RNA Microprep Kit (R1051; Zymo Research, Irvine,
CA) following the manufacturer’s protocol. Total RNA (10–100 ng)
was used for complementary DNA (cDNA) synthesis using a
commercially available cDNA synthesis kit (iScript; Bio‐Rad, Portland,
ME) following the instructions of the manufacturer. The synthesized
cDNA was amplified with a real‐time polymerase chain reaction
(RT‐PCR) system (ViiA 7; Life Technologies) using a Power SYBR
Green PCR Master Mix Kit (Life Technologies) according to the
manufacturer’s instructions. The following PCR primer pair for the
amplification of rat HIF1α gene was used: 5′‐GCGAGAACGAGAAGA
AAAATAGGA‐3′ and 5′‐GGGGAAGTGGCAACTGATGA‐3′. The
β‐actin was used as an internal control and was amplified with the
following primers: 5′‐CCTCGCCTTTGCCGATCC‐3′ and 5′‐GCGCG
GCGATATCATCATCC‐3′. The following protocol was used for the
thermal cycler: 50°C for 2min, 95°C for 10min, 42 cycles at 95°C for
14 s and 60°C for 1min. The relative messenger RNA (mRNA)
expression was quantified in duplicate using the comparative
Ct (ΔΔCt) method on the ViiA 7 real‐time PCR system.
2.6 | Image quantification
All fluorescent microscopy images of the stained cells were
quantified using the built‐in functions of the ImageJ software:
conversion to greyscale, subtraction of the background, enhance-
ment of the image contrast, and normalization of the average
intensity. The average intensities (normalized against the minimum
and maximum intensity of cell images) were rescaled to reflect
percentages. All data were plotted via curve fitting using nonlinear
regression analysis.
2.7 | Statistical analysis
The quantitative data are presented as the mean ± standard error of
the mean from three to ten devices (n = 3–10) and were assessed
using one‐way ANOVA and Tukey’s test. The p values <.05 were
considered to be statistically significant.
3 | RESULTS
In this study, we used our MPOC device as a progressive hypoxia‐on‐
a‐chip platform by creating an oxygen gradient of 0.3–6.9% via the
use of chemical oxygen quenchers in a fully oxygenated media rather
than generating the oxygen gradient with a nitrogen/carbon dioxide
mixture. We first characterized the generated oxygen gradient in the
MPOC device. We then showed in tissue‐culture plates that the
chemicals, sulfite and cobalt, used to induce the oxygen gradient did
not affect the cell viability directly. Upon establishing the safe ranges
for the chemicals used, we investigated whether the established
oxygen gradient, in the MPOC device, resulted in a hypoxia gradient
in the primary rat hepatocytes by assessing cell viability, hypoxia‐
marker pimonidazole levels, ROS production, and HIF1α expression
in cells exposed to different oxygen concentrations. We note that
similar oxygen gradients have been reported in the rat liver
compared to the human liver (Allen et al., 2005; Kietzmann, 2017;
Lautt, 2009; M, 1996; Martinez et al., 2008).
3.1 | Oxygen gradient generation in the MPOC
device
There are two different methods to simulate hypoxic conditions:
direct bubbling of gas of the desired composition (e.g., 95% N2 and
5% CO2; physically induced hypoxia) and using oxygen quenchers
(chemically induced hypoxia; Jiang et al., 2011). Here, we used the
latter, where gradients in sulfite and cobalt were utilized to gradually
quench the oxygen and generate an oxygen gradient in the MPOC
device (Abudara et al., 2002; Grasselli et al., 2005; Jiang et al., 2011;
Shimizu et al., 1996). This approach reduces the complexity and
footprint of the system by alleviating the need to use large gas tanks
and their additional tubing and pumping requirements. To accomplish
the chemical quenching approach and to assess the concentration
range necessary for the MPOC device, we first measured the
equilibrium oxygen concentration in solutions of 0% sulfite/0 µM
cobalt, 0.25% sulfite/25 µM cobalt, 0.5% sulfite/50 µM cobalt, 0.75%
sulfite/75 µM cobalt, 1% sulfite/100 µM cobalt, 100 µM cobalt, 1%
sulfite, and 95% N2/5% CO2 using the DO meter (Table S1).
Measured oxygen concentrations decreased from 15.9% to 0% as
the concentrations of sulfite and cobalt increased from 0% sulfite/
0 µM cobalt to 1% sulfite/100 µM cobalt (Figure 2a). Moderate
hypoxia of 1–3% O2 was generated in the solution of 0.25% sulfite/
25 µM cobalt and 0.5% sulfite/50 µM cobalt. The solution of 1%
sulfite generated severe hypoxia of 0% oxygen while the solution of
100 µM cobalt maintained an oxygen level of approximately 14.8%.
These results are in accordance with the fact that sulfite plays a
significant role in oxygen removal, and cobalt acts as a metal chelator
to prevent cytotoxicity of sulfite (Zhongbao; & Jingqi, 2002).
Based on these results, we selected 1% sulfite/100 µM cobalt as
the extreme input for the creation of the oxygen gradient in the
MPOC device to capture both severe and mild hypoxia as well as
normoxia. We simulated the concentration gradient of sodium sulfite
with a diffusion coefficient of 1.2 × 10−9 m2/s in water (Leaist, 1985)
and a molecular weight of 126Da at a flow rate of 30–120 µl/hr in
the MPOC device using COMSOL® Multiphysics (COMSOL Inc.,
Burlington, MA; Figure 2b). These simulations showed that we were
able to establish well‐separated compartments of different sodium
sulfite concentrations using these flow parameters. We created the
concentration gradient of sulfite and cobalt in the MPOC device by
mixing cell culture media—DMEM and DMEM media supplemented
with 1% sulfite and 100 µM cobalt via the gradient generator with a
flow rate of 120 µl/hr under cell‐free condition. The two extreme
inlets of the gradient generator are shown in Figure 2b: 0% sulfite/
0 µM cobalt and 1% sulfite/100 µM cobalt, corresponding to 15.9%
and 0% oxygen, respectively. We detected the oxygen gradient along
the width of the device via the oxygen‐sensing VisiSens system
(PreSens/TD system; GmbH, Germany; Figure S1). A descending
oxygen concentration profile across the cell culture chamber was
obtained along the ascending gradient of sulfite and cobalt (Figure
2c,d). The oxygen level in Channel 1, which was perfused with 0%
sulfite/0 µM cobalt solution, was approximately 6.9%, while the
oxygen level in Channel 5, which was perfused with 1% sulfite/
100 µM cobalt solution, was approximately 0.3%.
3.1.1 | Cytotoxicity of sulfite and cobalt in well
plate hepatocyte cultures
We then investigated the cytotoxicity of sulfite and cobalt and
assessed the viability of hepatocytes incubated with these chemicals
in tissue‐culture plates before conducting experiments in the MPOC
device. Primary rat hepatocytes cultured in well plates were treated
with media containing different concentrations of sulfite and cobalt
and with 95% N2/5% CO2 (Supporting Information text, Figure S2).
The results showed that the 1% sulfite/100 µM cobalt media, which
was used for oxygen gradient generation in the MPOC device, did not
result in significant toxicity for the first 2 hr, which is the time frame
for the rest of the experiments conducted in this study.
3.2 | Confirmation of the hypoxia gradient in
hepatocytes in response to the oxygen gradient in the
MPOC device
Pimonidazole is a common hypoxia marker that is reductively
activated in hypoxic cells and forms adducts via stable covalent
bonding with thiol‐containing proteins (Aguilera & Brekken, 2014).
Hypoxic cells can then be recognized via immunohistochemical
detection of this hypoxia marker. To confirm that we can indeed
establish intracellular hypoxia in a gradual fashion in the MPOC
device, we quantified the presence of pimonidazole adducts in
hepatocytes upon oxygen gradient exposure. Primary rat hepato-
cytes were perfused with the media containing the oxygen quenchers
supplemented with 200 µM pimonidazole hydrochloride at a flow
rate of 120 µl/hr for 2 hr. After exposing cells to the oxygen gradient,
we stained pimonidazole adducts with hypoxyprobe ATTO 594 and
F IGURE 2 Oxygen gradient in the MPOC device. (a) The plot of measured oxygen levels versus varying sulfite and cobalt concentrations in
water where an oxygen range of 15.9–0% was measured. The measurements were performed in 50ml conical tubes. (b) Simulation of the
oxygen gradient by COMSOL Multiphysics. (c) Plotted steady‐state oxygen gradient profile of the MPOC device after perfusion with 0% sulfite/
0 µM cobalt and 1% sulfite/100 µM cobalt, showing a gradient of 6.9–0.3% O2. (d) Representative image of oxygen concentration distribution in
the MPOC device measured by the Presens system. Inlet 1: 0% sulfite/0 µM cobalt and Inlet 2: 1% sulfite/100 µM cobalt. All data were obtained
from at least three different experiments. MPOC, Metabolic Patterning on a Chip [Color figure can be viewed at wileyonlinelibrary.com]
observed an increasing gradient of the stain across the width of the
device (Figure 3). Hepatocytes in Channel 1, perfused at an oxygen
concentration of 6.9%, displayed low fluorescence intensity, similar
to that of the control group (perfused with DMEM media only). In
contrast, hepatocytes in Channel 5, perfused at an oxygen
concentration of 0.3%, displayed high fluorescence intensity indicat-
ing high levels of intracellular hypoxia.
3.3 | Cell viability of hepatocytes cultured in the
MPOC device
After confirming the intracellular hypoxia patterning of hepatocytes, we
investigated cell viability in response to the oxygen gradient in theMPOC
device. Similar to previous experiments, hepatocytes were perfused with
varying amounts of oxygen quenchers for 2 hr. Cell viability was analyzed
by staining the cells with the live/dead assay kit and TMRM reagent, as
described in Section 2. Ethidium homodimer‐1 staining demonstrated
that most cells remained viable in Channel 1, where hepatocytes were
cultured at 6.9% O2, similar to that of the control group perfused with
DMEM media only (Figure 4a). In contrast, the cell viability of
hepatocytes decreased to approximately 80% in Channel 5, where
hepatocytes were exposed to 0.3% O2. In addition, the activities of both
esterase, responsible for the hydrolysis of Calcein‐AM, and the
mitochondrial membrane potential, an indicator of cell viability and
metabolism, were decreased to approximately 40–50% along with the
oxygen gradient (Figure 4b). Cell viability of hepatocytes under the
hypoxia gradient in the MPOC can be affected by cells in the neighboring
channels. The MPOC device was specifically designed to allow for such
interactions that draw upon the continuous nature of the tissue and
gradients in the liver sinusoid in vivo. For instance, the loss of cell viability
in Channel 5 could negatively affect the cell viability of the neighboring
channel. On the other hand, cells in the normoxic Channel 1 might have a
positive paracrine effect on cells in the neighboring hypoxia channel.
3.4 | ROS production of hepatocytes in response to
the oxygen gradient in the MPOC device
The cell viability loss caused by low oxygen concentration in the liver
is associated with the generation of ROS (Busek, Stefan, Steege,
Klotzbach, & Sonntag, 2016; Eltzschig & Eckle, 2011; Hockel &
Vaupel, 2001). Particularly, these species are involved in key
mechanisms leading to cell dysfunction and death under hypoxic
conditions. ROS can be accumulated in hypoxic hepatocytes, unlike
normal cells due to the imbalance of ROS production and removal
towards the pro‐oxidative state (Jaeschke, 2000). We investigated
ROS accumulation in response to the applied oxygen gradient.
Following the perfusion in the MPOC device, primary rat hepatocytes
were stained with ROS detection reagent CM‐H2DCFDA. The
highest ROS production was observed in Channel 5 where the
hepatocytes were exposed to severe hypoxia. The lowest expression
levels were observed in Channel 1, where cells were cultured under
normoxic conditions (Figure 5). Image quantification of ROS staining
F IGURE 3 Hypoxia gradient in primary rat hepatocytes in the MPOC device. Hepatocytes cultured in the MPOC device were perfused with
media supplemented with 200 µM pimonidazole and were exposed to the oxygen gradient created by 0% sulfite/0 µM cobalt and 1% sulfite/
100 µM cobalt for 2 hr. The control group consisted of cells perfused with DMEM media only. Afterward, cells were stained with hypoxyprobe
ATTO 594 to detect the by‐product of pimonidazole. An increasing gradient of hypoxyprobe ATTO 594 was observed along the decreasing
oxygen gradient across the width of the device. Image quantification for hypoxyprobe ATTO 594 staining was performed via the ImageJ
software. All data met p < .05 except that control versus Channels 1 and 2; Channel 1 versus Channel 2; and Channel 2 versus Channel 3 are not
significant (one‐way ANOVA n = 6, Tukey’s test). The data point of Channel 1 in the experiment of the oxygen gradient is similar to that of
Channel 1 in the control experiment in the graph. Scale bar: 400 µm. ANOVA, analysis of variance; DMEM, Dulbecco’s modified eagle’s medium;
MPOC, Metabolic Patterning on a Chip [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 4 Cell viability of primary rat hepatocytes in the MPOC device. Hepatocytes cultured in the MPOC device were exposed to an oxygen
gradient created by 0% sulfite/0 µM cobalt and 1% sulfite/100µM cobalt for 2 hr. Control groups consisted of cells perfused with DMEM media only.
Afterward, cells were stained with (a) EthD and Hoechst to assess cell viability. The cell viability of hepatocytes was decreased to approximately 80%
along the hypoxia gradient across the width of the device, while hepatocytes in the control group (perfused with oxygen‐dissolved DMEM media)
remained viable. Image quantification was performed via the ImageJ software. All data met p< .05 except that control versus Channels 1, 2, and 3;
Channel 1 versus Channels 2, 3, and 4; Channel 2 versus Channels 3 and 4; Channel 3 versus Channel 4; and Channel 4 versus Channel 5 are not
significant (one‐way ANOVA n=5, Tukey’s test). Scale bar: 400 µm. (b) TMRM and calcein staining. The metabolic activity was decreased along the
hypoxia gradient. Image quantification was performed via the ImageJ software. For the TMRM staining, all data met p< .05 except that control versus
Channels 1, 2, and 3; Channel 1 versus Channels 2 and 3; Channel 2 versus Channel 3; Channel 3 versus Channel 4; and Channel 4 versus Channel 5 are
not significant (one‐way ANOVA n=6, Tukey’s test). For the calcein staining, all data met p< .05 except that control versus Channels 1 and 2; Channel 1
versus Channel 2; Channel 3 versus Channel 4; and Channel 4 versus Channel 5 are not significant (one‐way ANOVA n=6, Tukey’s test). Scale bar:
400 µm. ANOVA, analysis of variance; DMEM, Dulbecco’s modified eagle’s medium; MPOC, Metabolic Patterning on a Chip [Color figure can be viewed
at wileyonlinelibrary.com]
demonstrated an ascending gradient profile of ROS generation
across the width of the device.
3.5 | HIF1α expression profile of hepatocytes in
response to the oxygen gradient
The ROS generation in hypoxic cells triggers the activation of HIF‐
αs, which are the key mediators of cell survival. In hypoxic tissue,
they regulate numerous genes associated with cellular adaptations
to hypoxia, whereas in the normal tissue, these factors are
degraded by the Von Hippel‐Lindau protein and proteasomes
(Covello et al., 2006; Das et al., 2008; Keith et al., 2011; Moreno‐
Manzano et al., 2010).
We investigated HIF1α expression in primary rat hepatocytes in
response to the generated oxygen gradient. After the perfusion in the
MPOC device, we stained the cells with HIF1α antibody and observed a
slightly ascending gradient of HIF1α across the width of the device
(Figure 6a). Hepatocytes in Channel 5, exposed to severe hypoxia,
displayed a higher fluorescence intensity compared to that of hepato-
cytes in Channel 1. We then quantified the mRNA expression of HIF1α
via RT‐PCR after collecting the cells from each channel of the cell culture
chamber of the MPOC device. Similar to the HIF1α antibody staining,
hepatocytes exposed to severe hypoxia revealed higher HIF1α mRNA
expression levels along the increasing hypoxia gradient (Figure 6b).
Compared to cells in Channel 1, cultured under normoxic conditions, an
approximately 3‐fold increase in HIF1α mRNA levels was observed in
cells cultured under hypoxic conditions in Channel 5.
4 | DISCUSSION
Previously, we introduced the MPOC device capable of creating
metabolic patterns in a microfluidic platform via actively enforced
concentration gradients of different inducers. Here, we used this device
to establish an in vitro microfluidic hypoxia model that can capture a
broad range of oxygen concentrations from the physiologically relevant
normoxia to severe hypoxia. The MPOC device was perfused with 0%
sulfite/0 µM cobalt and 1% sulfite/100 µM cobalt solutions to generate a
chemically induced oxygen gradient in the target range of 0–15.9%. On
the other hand, direct oxygen measurements in the MPOC device
showed that an oxygen gradient of 0.3–6.9% was achieved (Figure 2).
This result suggests that the explicit characterization of the oxygen
gradient in the MPOC device is critical for the interpretation of our
results. The simple predictions of flow simulations combined with the use
of oxygen measurements of sulfite/cobalt mixtures in stationary well‐
equilibrated solutions did not translate to our measurements in the
device. We hypothesize that this discrepancy could be a result of (a)
different measurement methods and the lack of measurement resolution
in smaller footprint devices such as ours but more so; (b) rapid oxygen
diffusion and high sulfite/cobalt concentration channels acting as oxygen
sinks for the overall device as follows. Oxygen (16Da) is smaller in size
than sulfite (126Da), resulting in a larger diffusion coefficient. Thus,
oxygen could easily diffuse from one channel to the next, subsequently
getting quenched by the sulfite, a very potent quencher of oxygen,
leading to a decrease in overall oxygen concentration. The fifth channel
perfused with 1% sulfite/100µM cobalt might have become a sink for the
F IGURE 5 ROS generation of primary rat hepatocytes in response to the hypoxia gradient in the MPOC device. Following perfusion with the
oxygen gradient generated by 0% sulfite/0 µM cobalt and 1% sulfite/100 µM cobalt, cells were stained with CM‐H2DCFDA to detect ROS
levels. An increasing pattern of ROS accumulation was observed along the hypoxia gradient across the width of the device. Control groups
consisted of cells perfused with DMEM media only. Image quantification was performed using ImageJ software. All data met p < .05 except that
control versus Channel 1; and Channel 1 versus Channel 2 are not significant (one‐way ANOVA n = 10, Tukey’s test). Scale bar: 400 µm.
ANOVA, analysis of variance; DMEM, Dulbecco’s modified eagle’s medium; MPOC, Metabolic Patterning on a Chip; ROS, reactive oxygen
species [Color figure can be viewed at wileyonlinelibrary.com]
whole system, resulting in a global quenching effect rather than a local
and channel‐specific one. Nevertheless, the established oxygen gradient
of 0.3–6.9% is a unique normoxia‐hypoxia gradient model, capturing both
the physiologically relevant oxygen levels along the liver sinusoid and the
hypoxic conditions in the liver ischemia. The pimonidazole staining
further demonstrated that we successfully created an intracellular
hypoxia gradient along the width of the cell culture chamber, where
hepatocytes exhibited increasing levels of hypoxia with decreasing
concentrations of oxygen. As shown in Figure 3, hepatocytes exposed
to severely oxygen‐depleted media became hypoxic cells (e.g., cells in
Channels 4 and 5) while hepatocytes exposed to physiologically relevant
oxygen levels did not exhibit a statistically significant difference in their
amount of pimonidazole (e.g., Channels 1 and 2) compared to the control
group.
As the next step, we assessed cell viability and metabolism. Along
the oxygen gradient of 6.9–0.3%, the cell viability, and metabolic
activity decreased to 80% and 40–50%, respectively (Figure 4).
Considering that the mitochondrial activity depends on oxygen
availability, the decrease in TMRM accumulation is well understood.
Thus, oxygen deprivation and severe hypoxia impaired the metabolic
activity of the cells, even though its effect on cell viability was less
drastic. In addition, the reduced oxygen concentration induces the
generation of ROS such as superoxide, hydrogen peroxide, hydroxyl
radical, hydroxyl ion, and nitric oxide which are by‐products of
mitochondrial electron transport chain (Hancock, Desikan, & Neill,
2001). Their accumulation causes toxicity and cellular DNA damage
through oxidative stress, which eventually results in apoptosis.
Quantification of ROS accumulation in response to the oxygen
gradient in the MPOC device indicated that hepatocytes exposed to
severe hypoxia generated high levels of ROS due to increased
oxidative stress, while hepatocytes exposed to normoxia exhibited
less oxidative stress (Figure 5). Under severe hypoxic conditions, the
cells die because of excessive ROS generation, which correlated well
with the 20% decrease of cell viability and up to 50% reduction in
mitochondrial and esterase activities in Channel 5 perfused with an
oxygen concentration of 0.3%. HIFs are involved in the metabolic
adaptation of ischemic tissues to maintain cellular viability for a
longer period. In the MPOC device, HIF1α expression was
significantly upregulated in the hypoxic microenvironment (Figure
6). The ascending trend of HIF1α expression of hepatocytes in
response to the increasing hypoxia gradient exhibits a close
correlation with the increasing ROS accumulation. Low oxygen levels
cause ROS generation in the cells, resulting in oxidative stress, and
they trigger HIFα activation to adapt to the abnormal environment as
in the case of severe hypoxia and ischemia.
These results demonstrate that we established a progressive
hypoxia‐on‐a‐chip platform, where an oxygen gradient of 0.3–6.9%
was generated, capturing a wide range of physiologically relevant
oxygen concentrations, ranging from normoxia to severe hypoxia. We
showed the applicability of this platform by confirming intracellular
F IGURE 6 HIF1α expression of primary rat hepatocytes in response to the hypoxia gradient in the MPOC device. (a) Hepatocytes cultured
in the microfluidic device were exposed to the oxygen gradient created by 0% sulfite/0 µM cobalt and 1% sulfite/100 µM cobalt for 2 hr. Cells
were stained with HIF1α antibody following the perfusion. HIF1α expression was slightly increased along the increasing hypoxia gradient across
the width of the device. (b) HIF1α mRNA levels were quantified via RT‐PCR analysis after inducing hepatocytes with the oxygen gradient
created by two different concentrations of sulfite/cobalt for 2 hr. An ascending gradient of HIF1α mRNA fold change was obtained along with
the width of the device. The control group was cultured with 0% sulfite/0 µM cobalt. All data met p < .05 except that control versus Channels 1,
2, and 3; Channel 1 versus Channels 2 and 3; Channel 2 versus Channel 3; Channel 3 versus Channel 4; and Channel 4 versus Channel 5 are not
significant (one‐way ANOVA n = 6, Tukey’s test). Scale bar: 400 µm. ANOVA, analysis of variance; HIF, hypoxia‐inducible factor; MPOC,
Metabolic Patterning on a Chip; mRNA, messenger RNA [Color figure can be viewed at wileyonlinelibrary.com]
hypoxia establishment in hepatocytes, by evaluating cell viability and
metabolic activity, and by demonstrating the regulation of hypoxia‐
associated factors, ROS, and HIFs in response to the applied oxygen
gradient. This progressive hypoxia model can be further used to
study the mechanisms and regulations of these factors in hypoxia‐
associated liver diseases. Furthermore, it can be utilized in studies of
other disease models such as NAFLD where carbohydrate and lipid
metabolisms are heavily reliant on the availability of oxygen.
Specifically, the lower concentrations of oxygenis hypothesized to
result in more drastic fat accumulation (Schleicher, Dahmen, Guthke,
& Schuster, 2017). Accordingly, this device could potentially be
employed to understand the relation between oxygen deprivation
and fat accumulation in hepatocytes.
5 | CONCLUSIONS
In this study, we built upon our recent MPOC device to create a
progressive hypoxia on‐a‐chip platform. In this platform, primary rat
hepatocytes were perfused with two extreme inlets of 0% sulfite/
0 μM cobalt and 1% sulfite/100 μM cobalt to create an oxygen
gradient of 0.3–6.9%. This range captures both physiologically
relevant normal zonal conditions and severely hypoxic conditions
relevant for injury and disease conditions. The cell viability of
hepatocytes in response to the hypoxia gradient decreased to
approximately 80% along the increasing hypoxia gradient. Increasing
levels for the hypoxia‐marker pimonidazole, ROS accumulation, and
HIF expression were established along the descending oxygen
gradient. These results demonstrated that our platform was able to
replicate the distinct metabolic activities of hepatocytes exposed to
oxygen gradients, mimicking the normal physiology as well as the
pathological state of injured liver tissue. As such, this platform could
be used for the study of various aspects of liver physiology, including
the role of oxygen and hypoxia‐associated mechanisms in healthy
liver and liver diseases, in addition to the study of drug toxicity and
efficacy under oxygen‐limited conditions, specifically the efficacy of
hypoxia‐activated prodrugs that are activated in the hypoxia
microenvironment (Hunter, Wouters, & Wilson, 2016). While we
have studied short‐term responses to oxygen gradients in this work,
our ultimate goal is to use the MPOC device to study the long‐term
effects of oxygen gradients on fully recapitulated liver tissues with
multiple cell types combining our approach here with previous long‐
term microfluidic hepatic culture and coculture models from our lab
(McCarty et al., 2014; Prodanov et al., 2016).
Beyond liver and hypoxia‐associated liver diseases, varying levels
of hypoxic microenvironments are also observed in other tissues
such as solid tumors and wound tissues (Kim et al., 2018; McKeown,
2014; Reichner & Albina, 2004; Samanta, Gilkes, Chaturvedi, Xiang, &
Semenza, 2014; Sen, 2009). Low oxygen concentration and poor
oxygen delivery to the tissue result in abnormal cellular metabolism
and function; and can lead to poor therapy response to cancer
treatment, delay of wound healing, and inflammation (Kim et al.,
2018; Reichner & Albina, 2004; Sen, 2009). The advancement of in
vitro platforms, that are capable of simulating various oxygenation
conditions simultaneously, can facilitate and accelerate research on
the role of hypoxia in these tissues and possible remedies for the
adverse outcomes due to hypoxia. Our progressive hypoxia‐on‐a‐chip
model, as presented here, can be used as a platform (a) to understand
the role of hypoxia‐associated factors in physiological and patho-
physiological state of the liver; (b) to investigate other disease
models such as NAFLD where oxidative stress plays a role in disease
progression as we have recently demonstrated (Bulutoglu et al.,
2019); (c) to study the complexity and heterogeneity of tissue healing
and therapy processes; and (d) to assess the safety and efficacy of
new drugs for clinical use in a reproducible manner.
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